Amarin Corporation plc

NasdaqGM:AMRN 주식 보고서

시가총액: US$282.7m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Amarin 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Aaron Berg

최고 경영자

US$2.4m

총 보상

CEO 급여 비율25.4%
CEO 임기no data
CEO 소유권0.2%
경영진 평균 재임 기간2.1yrs
이사회 평균 재임 기간1.3yrs

최근 관리 업데이트

Recent updates

Amarin Corporation plc's (NASDAQ:AMRN) 28% Dip In Price Shows Sentiment Is Matching Revenues

Jun 06
Amarin Corporation plc's (NASDAQ:AMRN) 28% Dip In Price Shows Sentiment Is Matching Revenues

Amarin Corporation: Small Signs Of Recovery May Not Be Enough

Apr 16

Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues As Shares Take 27% Pounding

Mar 12
Little Excitement Around Amarin Corporation plc's (NASDAQ:AMRN) Revenues As Shares Take 27% Pounding

Amarin: Sarissa Is Giving Me Hope Again

Jan 15

Improved Revenues Required Before Amarin Corporation plc (NASDAQ:AMRN) Stock's 26% Jump Looks Justified

Jan 03
Improved Revenues Required Before Amarin Corporation plc (NASDAQ:AMRN) Stock's 26% Jump Looks Justified

Calculating The Fair Value Of Amarin Corporation plc (NASDAQ:AMRN)

Nov 19
Calculating The Fair Value Of Amarin Corporation plc (NASDAQ:AMRN)

Investors Don't See Light At End Of Amarin Corporation plc's (NASDAQ:AMRN) Tunnel

Sep 27
Investors Don't See Light At End Of Amarin Corporation plc's (NASDAQ:AMRN) Tunnel

We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth

Jul 18
We Think Amarin (NASDAQ:AMRN) Can Afford To Drive Business Growth

Is Amarin (NASDAQ:AMRN) In A Good Position To Deliver On Growth Plans?

Nov 11
Is Amarin (NASDAQ:AMRN) In A Good Position To Deliver On Growth Plans?

Amarin gains as activist Sarissa starts process for special meeting to replace some board members

Oct 11

Amarin down 21% on higher than normal daily volume

Aug 22

For Amarin, Something Wishful This Way Comes

Aug 14

Amarin Q2 2022 Earnings Preview

Aug 02

HLS Therapeutics gets reimbursement for Vascepa in Ontario

Jul 25

Amarin's Vazkepa medicine gets final guidance from UK body for reimbursement and use

Jul 13

Amarin extends losses after Stat report on cardiovascular therapy

Jun 30

CEO 보상 분석

Aaron Berg 의 보수는 Amarin 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Mar 31 2024n/an/a

-US$53m

Dec 31 2023US$2mUS$622k

-US$59m

Sep 30 2023n/an/a

-US$52m

Jun 30 2023n/an/a

-US$38m

Mar 31 2023n/an/a

-US$91m

Dec 31 2022US$2mUS$567k

-US$106m

Sep 30 2022n/an/a

-US$92m

Jun 30 2022n/an/a

-US$100m

Mar 31 2022n/an/a

-US$22m

Dec 31 2021US$3mUS$505k

US$8m

Sep 30 2021n/an/a

-US$2m

Jun 30 2021n/an/a

US$4m

Mar 31 2021n/an/a

US$927k

Dec 31 2020US$4mUS$458k

-US$18m

Sep 30 2020n/an/a

-US$16m

Jun 30 2020n/an/a

-US$13m

Mar 31 2020n/an/a

-US$19m

Dec 31 2019US$3mUS$438k

-US$23m

보상 대 시장: Aaron 의 총 보상 ($USD 2.45M )은 US 시장( $USD 1.62M ).

보상과 수익: 회사가 수익성이 없는 동안 Aaron 의 보상이 증가했습니다.


CEO

Aaron Berg (61 yo)

no data

테뉴어

US$2,448,149

보상

Mr. Aaron D. Berg is President & CEO at Amarin Corporation plc since June 2024. He had been Executive VP & President of U.S. at Amarin Corporation plc until June 2024 and served as its Interim President an...


리더십 팀

이름위치테뉴어보상소유권
Aaron Berg
CEO & Presidentno dataUS$2.45m0.15%
$ 435.7k
Thomas Reilly
Executive VP2yrsUS$2.20m0.021%
$ 59.1k
Steven Ketchum
Executive VP8.4yrsUS$2.35m0.16%
$ 453.2k
Jonathan Provoost
Executive VPless than a yearUS$659.26k데이터 없음
Jordan Zwick
Senior VP of Corporate Business Development & Investor Relations2.1yrs데이터 없음데이터 없음
Laurent Abuaf
President of Europe & Senior VPno data데이터 없음데이터 없음
Nabil Abadir
Chief Medical Officer of Global Medical Affairs2.2yrs데이터 없음데이터 없음
David Keenan
Executive VP of Technical Operations & President of Europe2.1yrs데이터 없음데이터 없음

2.1yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 관리: AMRN 의 관리팀은 경험 ( 2.1 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
John Climax
Chairman of Scientific Advisory Board18.1yrsUS$39.00k데이터 없음
Jan Wallace
Member of Scientific Advisory Board18.1yrs데이터 없음데이터 없음
Mark Pierce
Member of the Scientific Advisory Board18.1yrs데이터 없음데이터 없음
Reid Patterson
Member of the Scientific Advisory Board18.1yrs데이터 없음데이터 없음
Louis Sterling
Independent Non-Executive Director1.3yrsUS$629.35k0.016%
$ 45.2k
Odysseas Kostas
Independent Non-Executive Chairperson of the Board1.3yrsUS$650.41k0%
$ 0
Diane Sullivan
Independent Non-Executive Director1.3yrsUS$630.83k0%
$ 0
Keith Horn
Independent Non-Executive Director1.3yrsUS$632.09k0%
$ 0
Mark DiPaolo
Independent Non-Executive Director1.3yrsUS$621.00k0%
$ 0
Patrice Bonfiglio
Independent Non-Executive Director1.3yrsUS$626.87k0%
$ 0
Paul Cohen
Independent Non-Executive Director1.3yrsUS$622.06k0%
$ 0
Oliver O'Connor
Independent Non-Executive Director1.2yrsUS$611.85k0%
$ 0

1.3yrs

평균 재임 기간

56.5yo

평균 연령

경험이 풍부한 이사회: AMRN 의 이사회경험(평균 재직 기간 1.3 년)으로 간주되지 않으므로 새 이사회가 필요합니다.